Greatbatch Files Patent Infringement Complaint Against AVX in Federal Court Business Wire FRISCO, Texas -- April 26, 2013 Greatbatch Ltd., a wholly owned subsidiary of Greatbatch Inc., has filed a complaint in the U.S. District Court for the District of Delaware against AVX Corporation and AVX Filter Corporation. The complaint alleges that AVX has infringed a Greatbatch patent by manufacturing and selling filtered feedthrough assemblies used in implantable pacemakers and cardioverter defibrillators that incorporate its patented technology. US Patent 5,905,627 was issued to Richard Brendel and Robert Stevenson for an invention entitled Internally Grounded Feedthrough Filter Capacitor. The invention shields and decouples the terminal pins in implantable medical devices to prevent interference from externally generated electromagnetic fields from devices such as mobile phones. Greatbatch took ownership of key patents in this field when the company acquired Maxwell Electronics Group Inc. of Carson City, Nevada in 2001. Greatbatch is seeking undisclosed damages for lost profits and legal costs and an injunction against AVX prohibiting the infringement of Greatbatch patents and the misuse of the company's intellectual property. “Greatbatch takes seriously what it believes to be willful and deliberate patent infringement,” said Timothy McEvoy, vice president and general counsel at Greatbatch, Inc. “We will take all steps necessary to ensure that our intellectual property is protected.” About Greatbatch, Inc. Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neuromodulation, vascular and orthopaedic markets. Electrochem designs and manufactures batteries for high-end niche applications in the portable medical, energy, military, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at www.greatbatch.com. Contact: Greatbatch Ltd. Investor Relations: Betsy Cowell, 214-618-4982 email@example.com or Media: Christopher Knospe, 716-759-5727 firstname.lastname@example.org
Greatbatch Files Patent Infringement Complaint Against AVX in Federal Court
Press spacebar to pause and continue. Press esc to stop.